AstraZeneca
The role leads a distributed team to transform translational and biomarker data into AI‑ready, standardized data products that accelerate drug discovery and development. It bridges science, technology, and data leadership to deliver reusable, FAIR‑compliant datasets and drive enterprise‑wide data strategy and automation.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Manager, Translational Biomarker Data Pathways & Re-use
GSK plc
Computational Scientist – Biomarker Development (m/f/d)
tubulis
Associate Director, Translational Science (Neurology)
Eisai
Manager, Clinical Biomarker Assays, Translational Science - Neuroscience
Arvinas
Scientist II, Biomarker Sciences/Translational Sciences
Revolution Medicines
Clinical Biomarker Lead
Janux Therapeutics